Wednesday, July 8, 2009

Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model http://bit.ly/2GRkzH
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)